Literature DB >> 1612157

The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro.

C Feldman1, R Read, A Rutman, P K Jeffery, A Brain, V Lund, T J Mitchell, P W Andrew, G J Boulnois, H C Todd.   

Abstract

The interaction of Streptococcus pneumoniae with human ciliated upper respiratory mucosa was studied in an agar-embedded organ culture of nasal turbinate tissue, which only exposed the intact epithelial surface and its secretion. The ciliary beat frequency, measured along the edge of the organ culture, was slowed by 13% in the presence of S. pneumoniae after 16 h (p less than 0.05) compared with the control, and by 24% after 24 h (p less than 0.01). Light microscopy showed bacteria in a thickened gelatinous layer, which obscured the surface of the organ culture. Transmission and scanning electron microscopy confirmed the association of bacteria with the gelatinous layer above an epithelial surface which showed only minor changes compared to uninfected control organ cultures. Contact between bacteria and normal or damaged epithelial cells was not seen. S. pneumoniae in organ culture developed projections from their surface, which were not present after broth culture. S. pneumoniae interactions with epithelial-derived secretions, the formation of a thickened gelatinous layer, and the effects of bacterial toxins on ciliary motility, may be important during colonization of the respiratory tract.

Entities:  

Mesh:

Year:  1992        PMID: 1612157

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Streptococcus pneumoniae: transmission, colonization and invasion.

Authors:  Jeffrey N Weiser; Daniela M Ferreira; James C Paton
Journal:  Nat Rev Microbiol       Date:  2018-06       Impact factor: 60.633

4.  The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.

Authors:  F E Perry; J R Catterall
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

5.  Streptococcus pneumoniae Senses a Human-like Sialic Acid Profile via the Response Regulator CiaR.

Authors:  Karina Hentrich; Jonas Löfling; Anuj Pathak; Victor Nizet; Ajit Varki; Birgitta Henriques-Normark
Journal:  Cell Host Microbe       Date:  2016-09-01       Impact factor: 21.023

6.  Comparison of haemophilus influenzae type b interaction with respiratory mucosa organ cultures maintained with an air interface or immersed in medium.

Authors:  A D Jackson; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa.

Authors:  C F Rayner; A D Jackson; A Rutman; A Dewar; T J Mitchell; P W Andrew; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae.

Authors:  Lynnelle A Pittet; Luanne Hall-Stoodley; Melanie R Rutkowski; Allen G Harmsen
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

9.  Influenza and RSV make a modest contribution to invasive pneumococcal disease incidence in the UK.

Authors:  Emily J Nicoli; Caroline L Trotter; Katherine M E Turner; Caroline Colijn; Pauline Waight; Elizabeth Miller
Journal:  J Infect       Date:  2013-03-05       Impact factor: 6.072

10.  Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.

Authors:  Katie L Propst-Graham; Laurel C Preheim; Elizabeth A Vander Top; Mary U Snitily; Martha J Gentry-Nielsen
Journal:  BMC Microbiol       Date:  2007-10-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.